@article{fa16da03661540d090a95b0f2cfe2128,
title = "Efficacy and safety of low-dose otelixizumab anti-CD3 monoclonal antibody in preserving C-peptide secretion in adolescent type 1 diabetes:DEFEND-2, a randomized, placebo-controlled, double-blind, multi-center study",
author = "P. Ambery and Donner, {T. W.} and N. Biswas and J. Donaldson and J. Parkin and Dayan, {C. M.}",
year = "2015",
month = feb,
day = "1",
doi = "10.1089/dia.2015.1510",
language = "English (US)",
volume = "17",
pages = "S82--S83",
journal = "Diabetes Technology and Therapeutics",
issn = "1520-9156",
publisher = "Mary Ann Liebert Inc.",
}